Patent ID: 7105162

Claim:
A pharmaceutical composition for treating an individual formed by mixing: (a) one or more antigenic peptides which fit into and bind the binding fork of an MHC molecule which is expressed by said individual; and (b) an adjuvant selected from a group consisting of: (i) polyarginine with a degree of polymerization from about 15 to about 500, (ii) polylysine, (iii) polyornithine, (iv) histones, (v) protamines, (vi) polyethyleneimines, and (vii) a mixture thereof; wherein said adjuvant is capable of increasing the binding of said peptides to cells of said individual and/or the entry of said peptides into the antigen-presenting cells of said individual, and wherein said adjuvant thereby brings about an increase in the immunomodulatory activity of said peptides.